10 Biotech Trades for Second Half of 2011

Description:

According to Adam Feuerstein, "The biotech calendar for the second half of 2011 is filled with drug approval decisions and clinical trial outcomes, enough to keep biotech stocks jumping for the remainder of the year." Read more here.

>>Also: 10 Cheap Biotech Stocks That Could Soar

>>Also: 5 Dow Stocks Likely to Rise After Earnings

Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

5 Dividend Stocks Ready to Give Investors a Raise

10.17.14 | 10:28 AM

BALTIMORE (Stockpickr) -- There's an important lesson to be learned from the 7.7% decline that the S&P 500 has made from its all-time highs last ...

4 Big Stocks on Traders' Radars

10.17.14 | 03:17 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter